News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
STAAB THOMAS R II
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/13/2023 |
4
| STAAB THOMAS R II (CFO) has filed a Form 4 on LENSAR, Inc.|
Txns:
| Granted 6,656 shares
@ $0
Granted 23,295 options to buy
@ $2.65, valued at
$61.7k
|
|
| 12/07/2022 |
4
| STAAB THOMAS R II (CFO) has filed a Form 4 on LENSAR, Inc.|
Txns:
| Bought 2,025 shares
@ $3.162, valued at
$6.4k
Bought 727 shares
@ $3.156, valued at
$2.3k
|
|
| 01/13/2022 |
4
| STAAB THOMAS R II (CFO) has filed a Form 4 on LENSAR, Inc.|
Txns:
| Granted 15,000 shares
@ $0
Granted 52,500 options to buy
@ $6.04, valued at
$317.1k
|
|
| 04/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/10/2020 |
4
| STAAB THOMAS R II (CFO) has filed a Form 4 on LENSAR, Inc.|
Txns:
| Granted 19,276 shares
@ $0 |
|
| 09/17/2020 |
3
| STAAB THOMAS R II (CFO) has filed a Form 3 on LENSAR, Inc. |
| 02/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/26/2019 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 12/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2019 |
4
| STAAB THOMAS R II (Senior Vice President and CFO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Sold 7,250 shares
@ $7.72, valued at
$56k
Sold 2,500 shares
@ $7.45, valued at
$18.6k
Exercised 4,750 options to buy
@ $1.42, valued at
$6.7k
|
|
| 05/16/2019 |
4
| STAAB THOMAS R II (Senior Vice President and CFO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Sold 4,500 shares
@ $7.62, valued at
$34.3k
Sold 7,250 shares
@ $7.92, valued at
$57.4k
Exercised 4,500 options to buy
@ $1.42, valued at
$6.4k
Exercised 4,750 options to buy
@ $1.42, valued at
$6.7k
|
|
| 05/13/2019 |
4
| STAAB THOMAS R II (Senior Vice President and CFO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Sold 9,750 shares
@ $7.63, valued at
$74.4k
Sold 9,750 shares
@ $7.76, valued at
$75.7k
Exercised 9,750 options to buy
@ $5.51, valued at
$53.7k
Exercised 9,750 options to buy
@ $5.51, valued at
$53.7k
|
|
| 05/06/2019 |
4
| STAAB THOMAS R II (Senior Vice President and CFO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Sold 7,750 shares
@ $7.3, valued at
$56.6k
Sold 9,000 shares
@ $7.75, valued at
$69.8k
Exercised 7,750 options to buy
@ $5.51, valued at
$42.7k
Exercised 9,000 options to buy
@ $5.51, valued at
$49.6k
|
|
| 04/08/2019 |
4
| STAAB THOMAS R II (Senior Vice President and CFO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Sold 7,500 shares
@ $8.81, valued at
$66.1k
Exercised 7,500 options to buy
@ $5.51, valued at
$41.3k
|
|
| 01/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2019 |
4
| STAAB THOMAS R II (Senior Vice President and CFO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 785 shares
@ $8.07, valued at
$6.3k
|
|
| 12/21/2018 |
4
| STAAB THOMAS R II (Senior Vice President and CFO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 235,000 options to buy
@ $7.06, valued at
$1.7M
|
|
| 12/06/2018 |
4
| STAAB THOMAS R II (Senior Vice President and CFO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Sold 3,922 shares
@ $9.45, valued at
$37.1k
|
|
| 11/26/2018 |
4
| STAAB THOMAS R II (Senior Vice President and CFO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Sold 5,000 shares
@ $9.41, valued at
$47.1k
Sold 7,000 shares
@ $9.08, valued at
$63.6k
Sold 3,500 shares
@ $9.66, valued at
$33.8k
Exercised 5,000 options to buy
@ $5.45, valued at
$27.3k
Exercised 7,000 options to buy
@ $3.78, valued at
$26.5k
Exercised 3,500 options to buy
@ $3.78, valued at
$13.2k
|
|
| 11/21/2018 |
4
| STAAB THOMAS R II (Senior Vice President and CFO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Sold 75 shares
@ $8.3, valued at
$622.5
Sold 4,623 shares
@ $8.57, valued at
$39.6k
Sold 6,500 shares
@ $8.75, valued at
$56.9k
Exercised 75 options to buy
@ $3.78, valued at
$283.5
Exercised 4,623 options to buy
@ $3.78, valued at
$17.5k
Exercised 6,500 options to buy
@ $3.22, valued at
$20.9k
|
|
| 11/09/2018 |
4
| STAAB THOMAS R II (Senior Vice President and CFO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Sold 672 shares
@ $8, valued at
$5.4k
Sold 11,113 shares
@ $8.09, valued at
$89.9k
Sold 2,302 shares
@ $8.3, valued at
$19.1k
Exercised 672 options to buy
@ $3.22, valued at
$2.2k
Exercised 11,113 options to buy
@ $3.22, valued at
$35.8k
Exercised 2,302 options to buy
@ $3.78, valued at
$8.7k
|
|
| 11/07/2018 |
4
| STAAB THOMAS R II (Senior Vice President and CFO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Sold 215 shares
@ $8, valued at
$1.7k
Exercised 215 options to buy
@ $3.22, valued at
$692.3 |
|
| 11/06/2018 |
4
| STAAB THOMAS R II (Senior Vice President and CFO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Sold 7,356 shares
@ $7.78, valued at
$57.2k
Sold 3,500 shares
@ $7.96, valued at
$27.9k
Exercised 7,356 options to buy
@ $3.22, valued at
$23.7k
Exercised 3,500 options to buy
@ $3.78, valued at
$13.2k
|
|
| 10/23/2018 |
4
| STAAB THOMAS R II (Senior Vice President and CFO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Sold 3,150 shares
@ $7.45, valued at
$23.5k
Exercised 3,150 options to buy
@ $3.78, valued at
$11.9k
|
|
| 10/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/23/2018 |
4
| STAAB THOMAS R II (Senior Vice President and CFO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 3,979 shares
@ $5.59, valued at
$22.2k
|
|
| 01/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2017 |
4
| STAAB THOMAS R II (Senior Vice President and CFO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 100,000 options to buy
@ $5.04, valued at
$504k
|
|
| 09/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|
|